On Nov 11th the company was successfully redomiciled to Nevada leaving just the last administrative steps towards the completion of the merger in December.
twitter.com/SleepXcl.../1458810589854244869
FRANCE Patent No. EP11819507.2 renewed in September
twitter.com/SleepXcl.../1440953864321110017
UK Patent No. EP2608717 renewed in September
twitter.com/SleepXcl.../1433397722124591114
Israeli Patent No. 224854 renewed in August
twitter.com/SleepXcl.../1428311127822372866
SleepX also has a portfolio of FIVE patents some of which are used in Fitbit:
www.sleepxclear.com/ipportfolio
Intellectual property
The company’s technology is protected by patents in order to provide a strong IP protection, one of the Company's most important assets. Its technology, applications and products, both in the medical and nonmedical fields, are protected by the laws of the United States and other jurisdictions worldwide. The Company's measurement technology utilizes a technique that measures a range of physical parameters as a function of time to a level of accuracy previously unattainable.
The company's patent portfolio includes:
***SYSTEMS AND METHODS FOR SNORING DETECTION AND PREVENTION***
1. HIGH-SENSITIVITY SENSORS FOR SENSING VARIOUS PHYSIOLOGICAL PHENOMENA, PARTICULARLY USEFUL IN ANTI-SNORING APPARATUS AND METHODS.
2. APPARATUS FOR USE IN CONTROLLING SNORING AND SENSOR UNIT PARTICULARLY USEFUL THEREN.
3. APPARATUS AND METHOD FOR DIAGNOSING SLEEP QUALITY
4. ESTIMATION OF SLEEP QUALITY PARAMETERS FROM WHOLE NIGHT AUDIO ANALYSIS
5. APPARATUS AND METHOD FOR DIGNOSING OBSTRUCTIVE SLEEP APNEA
With distinctive innovative sensor technologies and algorithms, the Company is well-positioned to become a market leader in the snoring and obstructive sleep apnea treatment markets.
twitter.com/SleepXcl.../1438144977041825792
twitter.com/9to5Goog.../1437985162621505539
The company also signed an agreement with NewsDirect's PR Firm for upcoming press release and marketing capabilities once everything has been finalized and completed.
twitter.com/SleepXcl.../1437852011962191876
www.sleepxclear.com/
twitter.com/SleepXcl.../1458810589854244869
FRANCE Patent No. EP11819507.2 renewed in September
twitter.com/SleepXcl.../1440953864321110017
UK Patent No. EP2608717 renewed in September
twitter.com/SleepXcl.../1433397722124591114
Israeli Patent No. 224854 renewed in August
twitter.com/SleepXcl.../1428311127822372866
SleepX also has a portfolio of FIVE patents some of which are used in Fitbit:
www.sleepxclear.com/ipportfolio
Intellectual property
The company’s technology is protected by patents in order to provide a strong IP protection, one of the Company's most important assets. Its technology, applications and products, both in the medical and nonmedical fields, are protected by the laws of the United States and other jurisdictions worldwide. The Company's measurement technology utilizes a technique that measures a range of physical parameters as a function of time to a level of accuracy previously unattainable.
The company's patent portfolio includes:
***SYSTEMS AND METHODS FOR SNORING DETECTION AND PREVENTION***
1. HIGH-SENSITIVITY SENSORS FOR SENSING VARIOUS PHYSIOLOGICAL PHENOMENA, PARTICULARLY USEFUL IN ANTI-SNORING APPARATUS AND METHODS.
2. APPARATUS FOR USE IN CONTROLLING SNORING AND SENSOR UNIT PARTICULARLY USEFUL THEREN.
3. APPARATUS AND METHOD FOR DIAGNOSING SLEEP QUALITY
4. ESTIMATION OF SLEEP QUALITY PARAMETERS FROM WHOLE NIGHT AUDIO ANALYSIS
5. APPARATUS AND METHOD FOR DIGNOSING OBSTRUCTIVE SLEEP APNEA
With distinctive innovative sensor technologies and algorithms, the Company is well-positioned to become a market leader in the snoring and obstructive sleep apnea treatment markets.
twitter.com/SleepXcl.../1438144977041825792
twitter.com/9to5Goog.../1437985162621505539
The company also signed an agreement with NewsDirect's PR Firm for upcoming press release and marketing capabilities once everything has been finalized and completed.
twitter.com/SleepXcl.../1437852011962191876
www.sleepxclear.com/
